Because LMP1 is known to antagonize entry in the lytic cycle in some experimental models we hypothesized that LMP1 might block production of EA and VCA in NPC cells and therefore prevent an increase of circulating antibodies directed to these viral proteins [20]. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.